Infectious complications in pediatric patients treated with chronic peritoneal dialysis (CPD)

Peritoneal Dialysis International

Volumn 16, Issue SUPPL. 1, 1996, Pages

  Edefonti, Alberto ^a,c   Consalvo, Geltrude ^a   Pappalettera, Marco ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c Clinica Pediatrica De Marchi   (Italy)

Author keywords

Exit site and tunnel infections; Infections unrelated to CPD; Infectious complications; Pediatric chronic peritoneal dialysis; Peritonitis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEFTAZIDIME; CEPHALOSPORIN; PSEUDOMONIC ACID; RIFAMPICIN; VANCOMYCIN;

CATHETER INFECTION; CONFERENCE PAPER; HOST RESISTANCE; HUMAN; KIDNEY FAILURE; NUTRITIONAL STATUS; OTOTOXICITY; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL;

EID: 0029992889     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089601601s111     Document Type: Conference Paper

References (11)

1. Pierratos A. Peritoneal dialysis glossary. Perit Dial Bull 1984; 4:2-3.
2. Twardowski ZJ, Dobbie JW, Moore HL, et al. Morphology of peritoneal dialysis catheter tunnel: macroscopy and light microscopy. Perit Dial Int 1991; 11:237-51.
3. Johnson DW, Fleming SJ. The use of vaccines in renal failure. Clin Pharmacokinet 1992; 22(6):434-46.
4. Neu A, Case B, Lederman H, et al. IgG subclass levels in pediatric patients on chronic peritoneal dialysis. Pediatr Nephrol 1995; 9:186-8.
5. Jörres A, Topley N, Witowski J, et al. Impact of peritoneal dialysis solutions on peritoneal immune defense. Perit Dial Int 1993; 13(Suppl 2):S291-4.
6. Holmes JC. Peritoneal immune defense in continuous ambulatory peritoneal dialysis: clinical relevance and practical implications. Perit Dial Int 1993; 13(Suppl 2):S278-81.
7. Luzar MA. Exit-site infections in continuous ambulatory peritoneal dialysis: a review. Perit Dial Int 1991; 11:333-40.
8. Tranaeus A. Update on peritonitis incidence and treatment. XVth Annual Conference on Peritoneal Dialysis, Baltimore, MD, 1995.
9. Ad Hoc Advisory Committee on Peritonitis Management. Peritoneal dialysis-related treatment recommendations 1993 update. Perit Dial Int 1993;13:14-28.
10. De Fijter CWH, Verbrugh HA, Oe LP, et al. Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis. Kidney Int 1992; 42:947-50.
11. Piraino B, Bernardini J, Sorkin MI. The effect of Y-set on catheter infection rates in continuous peritoneal dialysis patients. Am J Kidney Dis 1990; 4:46-50.